Children’s Tylenol recalled
The U.S. Food and Drug Administration and McNeil Consumer Healthcare the issued a nationwide voluntary recall of certain children’s Tylenol products. McNeil Consumer Healthcare, a division of Johnson & Johnson and the manufacturer of Tylenol products, says only certain lots of the children’s medicine were recalled.
New York drug recall attorney alert-McNeil Consumer Healthcare recalls several children’s tylenol products for possible bacterial contamination.
New York, NY–Johnson & Johnson unit, McNeil Consumer Healthcare, issued a voluntary recall of some 57 different affected lot numbers of children’s Tylenol products in 21 different varieties. McNeil Consumer Healthcare is responsible for Tylenol, a popular pain and fever reducing medication sold over-the-counter and as a potentiating ingredient in numerous prescription pain medications. The voluntary drug recall was issued after the company discovered a possible bacterial contamination of their popular infant and children’s pain and fever medicine and reported it to the U.S. Food and Drug Administration (FDA) http://www.fda.gov.
The Tylenol maker discovered one of the inactive ingredients, of the children’s over-the-counter preparation, did not meet testing requirements for B. Cepacia (Burkholderia cepacia) a bacteria. The bacteria was found in raw material not used in the final Tylenol product. After the drug maker consulted the FDA, a precautionary voluntary recalled was issued. Leaders with Johnson & Johnson, a worldwide manufacturer based in New Brunswick, New Jersey, assert the Tylenol recall affects only the United States market and certain Tylenol products manufactured between April and June of 2008. No adverse events from the recalled drug have been reported. Wikipedia http://www.wikipedia.org defines Burkholder cepacia complex (BCC) as a group of Gram-negative bacteria with at least nine different species. B. Cepacia is a serious human pathogen which causes pneumonia in individuals who are immunocompromised or already suffer from an underlying lung disease like cystic fibrosis.
Legal news reporter Heather L. Ryan for New York drug injury attorneys.